2020/08/03 ALA -1000 Receive notice of patent allowance from the IP Australia.Post author:alarpharmPost published:25 . 8 . 2020Post category:Media releases You Might Also Like 2023/08/21 ALA-3000 has received the Notice of Eligibility of Grant from Intellectual Property Office of Singapore (IPOS) after the examination.(Patent Application No. 11202104792S) 23 . 8 . 2023 2024/03/14 ALA-3000 has received a notice of allowance from National Office of Intellectual Property of Vietnam (NOIP) after examination. (Patent Application No. 1-2021-03276) 15 . 3 . 2024 2021/08/25 ALA-1000 Receive notice of patent allowance from South Africa-Companies and Intellectual Property Commission Department of Trade and Industry (CIPC), Application No. 2019/00890. 3 . 9 . 2021 2024/02/05 ALA-2000 has received a notice of allowance from The Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM), India, after examination. (Patent Application No. 501360) 29 . 2 . 2024 2021/03/10 Breaking the Cycle of Opioid Addiction: Alar Presents Positive Interim Results of Long-acting Buprenorphine Injectable (ALA-1000) in Opioid Dependent Patients 10 . 3 . 2021
2023/08/21 ALA-3000 has received the Notice of Eligibility of Grant from Intellectual Property Office of Singapore (IPOS) after the examination.(Patent Application No. 11202104792S) 23 . 8 . 2023
2024/03/14 ALA-3000 has received a notice of allowance from National Office of Intellectual Property of Vietnam (NOIP) after examination. (Patent Application No. 1-2021-03276) 15 . 3 . 2024
2021/08/25 ALA-1000 Receive notice of patent allowance from South Africa-Companies and Intellectual Property Commission Department of Trade and Industry (CIPC), Application No. 2019/00890. 3 . 9 . 2021
2024/02/05 ALA-2000 has received a notice of allowance from The Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM), India, after examination. (Patent Application No. 501360) 29 . 2 . 2024
2021/03/10 Breaking the Cycle of Opioid Addiction: Alar Presents Positive Interim Results of Long-acting Buprenorphine Injectable (ALA-1000) in Opioid Dependent Patients 10 . 3 . 2021